Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway trial
Year: 2024
Type: article
Source: Annales d Endocrinologie
Authors: P. Kamenicky, P. Schwarz, L. Rejnmark, E. Gosmanova, A. Khan, N. Makita, Y. Takeuchi, Y. Imanishi, S. Sprague, D. Shoback, L. Kohlmeier, M. Rubin, A. Palermo, C. Gagnon, E. Tsourdi, C. Zhao, M. Makara, M. Ominsky, B. Lai, J. Ukena, C. Sibley, A. Shu
Institutions: Assistance Publique – Hôpitaux de Paris, Rigshospitalet, Aarhus University Hospital, Albany Medical College, McMaster University, The University of Tokyo, Toranomon Hospital, Okinaka Memorial Institute for Medical Research, Osaka Metropolitan University, University of Chicago, San Francisco VA Medical Center, University of California, San Francisco, Columbia University, Università Campus Bio-Medico, Campus Bio Medico University Hospital, Université Laval, Technische Universität Dresden, VMware (United States)
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403003233